Prenatal effects of oral versus intraperitoneal sodium arsenate in mice.
D000014:Abnormalities, Drug-Induced / Q000473:pathology; D000284:Administration, Oral; D000818:Animals; D001149:Arsenates / Q000008:administration & dosage / Q000633:toxicity*; D001151:Arsenic / Q000633:toxicity*; D001835:Body Weight / Q000187:drug effects; D005260:Female; D005313:Fetal Death / Q000139:chemically induced; D005333:Fetus / Q000187:drug effects / Q000502:physiology; D007274:Injections, Intraperitoneal; D008431:Maternal-Fetal Exchange; D051379:Mice; D011247:Pregnancy; D013723:Teratogens; D013997:Time Factors
D001149:Arsenates; D013723:Teratogens; D001151:Arsenic